Synevo Ukraine
Synevo Ukraine is the largest medical laboratory network in Ukraine, operating 360+ branches across 164 settlements and 8 centralized labs. Wholly-owned by Sweden's Medicover, it serves over 4 million clients annually with 1,200+ test types, B2C retail testing, B2B clinic/corporate accounts, and an NSZU government channel.
- Company typePublic
- Founded2007
- HeadquartersKyiv, Ukraine
- Headcount101–250
- GTM typeB2B and B2C
- OfferingServices
What Synevo Ukraine does
Synevo Ukraine (legal entity TOV 'Synevo Ukraina') is the largest medical laboratory network in Ukraine, operating 360+ physical patient service branches across 164 settlements and 8 centralized laboratories in Kyiv, Vinnytsia, Lviv, Chernivtsi, Odesa, Kherson, Dnipro, and Kharkiv. Founded in 2007 and headquartered in Kyiv, the company is a wholly-owned subsidiary of Swedish medical holding Medicover (Stockholm Stock Exchange: MCOV), which listed Synevo as the first Ukrainian medical company traded on an international exchange in 2017. Synevo employs over 2,500 staff and in 2025 served more than 4 million clients while performing 25.5 million tests across a menu of 1,200+ test types.
The platform is built on automated analyzers from leading global manufacturers (Roche Cobas 8000, Cobas PRO; Abbott Alinity i, ARCHITECT i2000SR; Sysmex XN-2000, CN-6000; BD SurePath and FocalPoint GS; Thermo Fisher Phadia 250; Bruker MALDI Biotyper; ZEISS Axioscope 5) connected to a centralized laboratory information system, with ISO 15189:2022 certification and participation in international quality control (RIQAS, RfB, INSTAND, Labquality). Recent product investment is centered on AI-augmented diagnostics — the Cytological Passport combines liquid-based cytology, BD FocalPoint AI imaging, and ZEISS expert microscopy — and Tissue Diagnostics offering immunohistochemistry with 200+ validated antibodies.
Synevo monetizes through three primary streams: (1) one-time pay-as-you-go laboratory testing for individual consumers ordered online or in-branch, with sample prices ranging from routine panels to 1,980 UAH pathomorphology tests; (2) a subscription/wallet program (RESULT Synevo) offering 20% bonus value on prepaid 1,000-5,000 UAH plans, generating annual recurring cash; and (3) B2B corporate and clinic accounts via a dedicated portal (corporate.synevo.ua) with MIS integration, business analytics, and negotiated pricing. In 2024 the company added a public-pay channel via a partnership with the National Health Service of Ukraine (NSZU) for government-reimbursed tests.
Synevo Ukraine firmographics
Firmographics- Name
- Synevo Ukraine
- Legal name
- Товариство з обмеженою відповідальністю «Сінево Україна»
- Website
- https://new.synevo.ua
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Synevo Ukraine is the largest medical laboratory network in Ukraine, operating 360+ branches across 164 settlements and 8 centralized labs. Wholly-owned by Sweden's Medicover, it serves over 4 million clients annually with 1,200+ test types, B2C retail testing, B2B clinic/corporate accounts, and an NSZU government channel.
- Ownership category
- akta.pro rank
Synevo Ukraine industry classification
Industry- Product category
- Medical Laboratory Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industry
- Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)
Keywords
Where Synevo Ukraine is headquartered
LocationHeadquarters
- HQ city
- Kyiv
- HQ country
- Ukraine
- HQ region
- Europe
Offices9 records
Markets served
Synevo Ukraine business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Laboratory Testing Services: One-time laboratory diagnostic tests for patients. Over 1,200 types of tests performed across 8 major laboratories. Tests ordered individually or as packages via online ordering or at branches.
- Subscription/Wallet Program (Підписка): Prepaid bonus program where customers purchase subscription plans (1,000-5,000 UAH) receiving 20% bonus on amounts, redeemable for laboratory tests at 1 bonus = 1 UAH rate. Annual billing cycle.
- Corporate/B2B Services: Laboratory services for medical clinics and corporate clients including employee health checkups, automated MIS integration, and corporate account management.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | 1,000 UAH subscription - 1,200 bonuses + 200 UAH benefit |
| Subscription | Annual | 3,000 UAH subscription - 3,600 bonuses + 600 UAH benefit |
| Subscription | Annual | 5,000 UAH subscription - 6,000 bonuses + 1,000 UAH benefit |
| Unit Pricing | Pay-as-you-go | Cytology Passport - 740 UAH |
| Unit Pricing | Pay-as-you-go | Cervical Screening Package - 1,770 UAH |
| Unit Pricing | Pay-as-you-go | Pathomorphological tests - from 760 to 1,980 UAH |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Synevo Ukraine product offering
Product offeringCore offering
Synevo Ukraine operates a national medical laboratory network performing more than 1,200 diagnostic test types across 8 centralized laboratories and over 360 branches in 164 Ukrainian settlements. It serves individual consumers through retail branch visits and online ordering, and serves corporate clients and medical clinics through a dedicated B2B portal with medical information system integration. The company is part of Swedish medical holding Medicover and offers specialized services including AI-assisted cervical cancer screening (Cytological Passport) and tissue diagnostics with immunohistochemistry.
Product overview
Synevo Ukraine is a European medical laboratory network offering a unified diagnostic services platform with multiple integrated modules. The core offering is medical laboratory testing services performing 1200+ types of tests across 8 regional laboratories and 360+ branches. This core platform is enhanced by specialized modules including the AI-powered Cytological Passport for cervical cancer screening (combining BD SurePath liquid cytology with automated BD FocalPoint GS AI analysis and ZEISS microscopy), Tissue Diagnostics (pathohistology, immunohistochemistry with 200+ antibodies, cytomorphology, second opinions, and intraoperative studies), and Subscription/Wallet services for discounted analysis payments. Additional modules include B2B corporate services with MIS integration capabilities and customer loyalty programs. The company operates within the international Medicover holding (Swedish healthcare diagnostics provider listed on Stockholm Stock Exchange).
Differentiator
Problem solved
Functional benefit
Products and services
- Laboratory Testing Services (Лабораторні послуги) Core medical laboratory diagnostic services performing over 1,200 types of tests across 8 modern laboratories in Kyiv, Vinnytsia, Lviv, Chernivtsi, Odesa, Kherson, Dnipro, and Kharkiv, supported by 360+ branch sample-collection points in 164 settlements across Ukraine. Tests are available to individual consumers via online ordering (synevo.ua), mobile app, or in-branch visits, delivering 25.5 million tests to 4+ million clients in 2025.
- Cytological Passport (Цитологічний паспорт) Innovative cervical cancer screening solution combining BD SurePath liquid-based cytology (FDA approved) with automated AI analysis via BD FocalPoint GS Imaging System and expert cytology verification on ZEISS Axioscope 5. Delivers structured digital reports with Bethesda 2014 classification and real cell images. Demonstrates +9.2% sensitivity for ASC-H, +9.8% for HSIL, and +24.5% for cervical cancer detection versus traditional methods, with 27% reduction in turnaround time.
- Tissue Diagnostics (Тканинна діагностика) Advanced pathomorphological diagnostic services including pathohistological research, immunohistochemical (IHC) studies using over 200 validated antibodies, cytomorphological studies using LBC method, second opinion consultations, and intraoperative express diagnostics. Performed using automated Epredia/Thermo Fisher and ZEISS equipment following CAP and Royal College of Pathologists protocols.
- Subscription Service (Підписка / РЕЗУЛЬТАТ Сінево) Prepaid bonus wallet subscription service that converts payments to bonus points with 20% extra value, redeemable for laboratory tests at 1 bonus = 1 UAH rate. Available in tariff plans of 1,000 UAH (1,200 bonuses), 3,000 UAH (3,600 bonuses), and 5,000 UAH (6,000 bonuses) on annual billing.
- Corporate Services (Бізнес-кабінет) B2B laboratory services for medical clinics and corporate clients, including automated pre- and post-analytical laboratory process integration with client medical information systems (MIS), a dedicated corporate account portal (corporate.synevo.ua), online ordering, business analytics, and partner loyalty programs. Covers employee health checkups (Check Up programs) and clinic patient referral testing.
- Home Nurse Visit Service (Візит медсестри) Mobile sample collection service where a nurse visits the patient's location (home or office) for sample collection, eliminating the need to visit a branch. Targeted at patients with mobility limitations, time-constrained professionals, and busy families.
Quantifiable outcome
- 25.5 million tests performed in 2025
- +3 more outcomes
Companies that use Synevo Ukraine
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Synevo Ukraine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
Synevo Ukraine partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and flagship.
- National Health Service of Ukraine (НСЗУ)coreSynevo partners with National Health Service of Ukraine to provide free laboratory tests under government healthcare program. Patients can access covered tests at Synevo branches through NSZU program.
- Territorial Defense (ТрО) - Laboratory PartnercoreSynevo received official status as 'Laboratory Partner of Territorial Defense' in 2022, providing diagnostic services to military personnel.
- Medicover (Sweden)flagshipSynevo Ukraine is part of Swedish medical holding Medicover, which provides diagnostic services in 16 European countries. Medicover IPO on Stockholm Stock Exchange in 2017. Synevo is the first Ukrainian medical company with shares listed on international exchange. Medicover operates 117 modern laboratories globally, 8 of which are in Ukraine.
- Roche Diagnostics (Switzerland)coreEquipment supplier for automated biochemical and immunochemical analyzers. Synevo uses Cobas 8000, Cobas PRO, Cobas c513, Cobas P512 pre-analytical systems, Cobas Connection Modules (CCM), Cobas s513 from Roche.
- Abbott (USA)coreEquipment supplier providing Alinity i, ARCHITECT i2000SR immunochemical analyzers, RealTime PCR systems m2000rt/m2000sp for infectious disease diagnostics.
- Sysmex (Japan)coreEquipment supplier for hematology (Sysmex XN-2000, Sysmex CN-6000 hemostasis), urinalysis (Sysmex UN-5000), and digital microscopy (Sysmex CellaVision DM 96).
- Becton Dickinson (USA)coreSupplier of BD SurePath liquid-based cytology system, BD FocalPoint GS AI imaging system for cervical cancer screening, BD PrepStain slide preparation system, BD PHOENIX M50 microbiology identification system.
- Thermo Fisher Scientific (USA)coreSupplier of Phadia 250 laboratory systems for allergy and autoimmune diagnostics using ImmunoCAP and EliA technologies. Equipment for histopathology processing.
- Bio-Rad (USA)coreSupplier of IH-1000 immunohematology testing systems for blood group determination (ABO, Rh, Kell systems).
- Euroimmun (Germany)coreSupplier of EUROIMMUN Analyzer I for infectious disease and allergy testing via ELISA, EUROLabWorkstation ELISA, and EuroBlotOne for immunoblotting diagnostics.
- Bruker (Germany)coreSupplier of MALDI Biotyper sirius IVD System for rapid automated microorganism identification via MALDI-TOF mass spectrometry (results in up to 15 minutes).
- ZEISS (Germany)coreEquipment supplier for tissue diagnostics microscopy - ZEISS Axioscope 5 for expert verification of cytology and histopathology specimens.
- RIQAS (UK)coreExternal quality assessment program (UK) - Synevo participates in international quality control alongside 50,000+ medical laboratories from 139 countries.
- INSTAND / DGKL-RfB (Germany)coreGerman external quality assessment organizations for laboratory proficiency testing.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Synevo Ukraine competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Synevo Ukraine social profiles
Digital presenceSynevo Ukraine compliance and trust
Trust signalCompliance6 records
Synevo Ukraine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synevo Ukraine leadership team
Management profileNumber of profiles
Profiles3 records
Synevo Ukraine subsidiaries and ownership
Company hierarchySubsidiaries10 records
Synevo Ukraine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synevo Ukraine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synevo Ukraine
What does Synevo Ukraine do?
Synevo Ukraine operates a national medical laboratory network performing more than 1,200 diagnostic test types across 8 centralized laboratories and over 360 branches in 164 Ukrainian settlements. It serves individual consumers through retail branch visits and online ordering, and serves corporate clients and medical clinics through a dedicated B2B portal with medical information system integration. The company is part of Swedish medical holding Medicover and offers specialized services including AI-assisted cervical cancer screening (Cytological Passport) and tissue diagnostics with immunohistochemistry.
Is Synevo Ukraine a public or private company?
Synevo Ukraine is a public company. It is classified as corporate owned and is currently operating.
When was Synevo Ukraine founded?
Synevo Ukraine was founded in 2007. It employs 101 to 250 people.
Where is Synevo Ukraine based?
Synevo Ukraine is headquartered in Kyiv, Ukraine, in the Europe region.
How does Synevo Ukraine make money?
Three revenue lines are on record. Laboratory Testing Services are the primary driver. The others are subscription/Wallet Program (Підписка) and corporate/B2B Services.
Does Synevo Ukraine have an API?
No public API is recorded for Synevo Ukraine.
What industry is Synevo Ukraine in?
Synevo Ukraine's product category is Medical Laboratory Diagnostics. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLACAMAJ, Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces. Its NAICS code is 621511 and its SIC code is 8071.